Indian Pharma Industry: Innovators, Generics, and Future Trends

The Indian pharma industry is like a complex game with different players.

Some companies are innovators, creating new drugs, which is risky but can bring big rewards.

Others make generics, which are cheaper versions of drugs after the original patent expires.

Generics are competitive, and prices drop fast.

The industry also involves branded generics, CRDMO (companies that help develop and manufacture drugs), and API (active pharmaceutical ingredients).

Companies are also investing in complex generics like biosimilars, and are also taking advantage of new opportunities, especially due to limitations on Chinese firms' pharmaceutical involvement.